Hyperthyroidism resident survival guide: Difference between revisions
MydahSajid (talk | contribs) |
MydahSajid (talk | contribs) |
||
Line 119: | Line 119: | ||
* Methimazole (MMI) is a drug of choice because of its lower side effects profile. | * Methimazole (MMI) is a drug of choice because of its lower side effects profile. | ||
* It should be continued for a minimum duration of 12 to 18 months. | * It should be continued for a minimum duration of 12 to 18 months. | ||
* Regular monitoring with TSH and TRAb should be done. |C03= | * Regular monitoring with TSH and TRAb should be done. |C03= <div style="float: left; text-align: left; height: 28em; width: 19em; padding:1em;">Total or near-total thyroidectomy is recommended. The advantages are: | ||
* High cure rate | * High cure rate | ||
* Zero recurrence rate with total thyroidectomy. }} | * Zero recurrence rate with total thyroidectomy. }} |
Revision as of 19:44, 9 January 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pervaiz Laghari, MD[2]
Overview
Hyperthyroidism and thyroid storm are disease states that result from thyroid hormone-induced hypermetabolism. The excess thyroid hormone is released from the thyroid gland as a result of excess thyroid hormone production, or by processes that disrupt the follicular structure of the gland with subsequent release of stored hormone [1]. Most patients with severe hyperthyroidism present with a dramatic symptom constellation. Hyperthyroidism's typical symptoms include palpitations,heat intolerance, increased bowel movement frequency tremor, anxiety, weight loss despite normal or increased appetite and shortness of breath.Goiter is commonly found on physical examination.
Specific organ systems
Cardiovascular | Heart rate is increased,Systolic hypertension ,pulse pressure is widened, congestive heart failure, Atrial fibrillation |
Neuropsychiatric | Anxiety, tremor, restlessness, irritability,insomnia,psychosis, agitation,depression, seizures |
Respiratory | Dyspnea, tracheal obstruction, exacerbate underlying asthma,Pulmonary arterial systolic pressure is increased |
Gastrointestinal | Weight loss,hyperphagia,hyperdefecation and malabsorption |
Skin | Sweating,Onycholysis,Hyperpigmentation,Thinning of the hair |
Eyes | Stare and lid lag, ophthalmopathy. |
Genitourinary | Urinary frequency and nocturia |
Hematologic | Normochromic, normocytic anemia |
Neck | Thymic enlargement |
Bone | Osteoporosis and an increased fracture risk |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Graves disease[2][3]
- Painless or transient (silent) thyroiditis[4]
- Toxic adenoma (Plummer disease)
- Toxic multinodular goiter
- Postpartum thyroiditis
- Hyeremesis gravidarum
- Subacute granulomatous (de Quervain) thyroiditis
- Drug-induced thyroiditis
Diagnosis
Shown below is an algorithm summarizing the diagnosis of hyprthyroidism according to the American Thyroid Association guidelines[5]. Serum TSH measurement has the highest sensitivity and specificity of any single blood test used in the evaluation of suspected thyrotoxicosis and should be used as an ini-tial screening test . However, when thyrotoxicosis is strongly suspected, diagnostic accuracy improves when aserum TSH, free T4, and total T3 are assessed at the initial evaluation. Serum TSH levels are considerably more sensitive than direct thyroid hormone measurements for assessing thyroid hormone excess. In overt hyperthyroidism, serum free T4,T3,or both are elevated, and serum TSH is subnormal (usually<0.01mU/L ina third-generation assay). In mild hyperthyroidism, serum T4 and free T4 can be normal, only serum T3 may be elevated, and serum TSH will be low or undetectable. The diagnosis of a thyrotoxic crisis is made entirely on the clinical findings. Most importantly, there is no difference in thyroid hormone levels between patients with "uncomplicated" thyrotoxicosis and those undergoing a thyroid storm.[6]
Clinical assessment of signs & symptoms for hyperthyroidism:
| |||||||||||||||||||||||||||||||||||||||||
Measure serum Thyroid stimulating hormone levels | |||||||||||||||||||||||||||||||||||||||||
Low TSH | High TSH | ||||||||||||||||||||||||||||||||||||||||
Mild hyperthyroidism: Serum T4 and T3 values in normal range or only T3 levels are elevated. | Overt hyperthyroidism: Both serum T3 and T4 levels elevated | Elevated serum T4 and T 3 levels | |||||||||||||||||||||||||||||||||||||||
Perform thorough physical examination of thyroid gland and look for signs for thyroid eye disease. Thyroid gland diffusely enlarged with symmetrical hypertrophy and new onset of ocular symptoms | Repeat TSH levels in serial dilution | ||||||||||||||||||||||||||||||||||||||||
Yes. Graves' disease | No | Positive | Negative | ||||||||||||||||||||||||||||||||||||||
Measure serum assays of TRAb and radioactive iodine uptake thyroid scan | High TSH levels due to hetrophilic antibodies | Look out for pituitary lesion | |||||||||||||||||||||||||||||||||||||||
Measurement of serum levels of human anti-mouse antibodies | * Perform MRI Brain
| ||||||||||||||||||||||||||||||||||||||||
Diffuse increase in iodine uptake | Localized increase in iodine uptake | Subnormal or absent uptake of iodine | |||||||||||||||||||||||||||||||||||||||
Graves' disease | Toxic nodular goiter | Subacute thyroiditis/ Postpartum thyroiditis | Factitious ingestion of thyroid hormones | Excess intake of iodine recently | |||||||||||||||||||||||||||||||||||||
High levels of thyroglobulin in serum | Low thyroglobulin levels | Measure spot urine iodine or 24 hour urine iodine level | |||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of Graves' disease according to the American Thyroid Association guidelines.
Overt Graves' disease | |||||||||||||||||||||||||||||||||||
Antithyroid medications | Radioactive iodine ablation | Surgery | |||||||||||||||||||||||||||||||||
| Total or near-total thyroidectomy is recommended. The advantages are:
| ||||||||||||||||||||||||||||||||||
Drug List
Drug | Initial daily dose | Mechanisim of action |
---|---|---|
Beta blocker | Propranolol 60 to 80 mg orally every four to six hours, | Control the symptoms and signs |
Thionamide | PTU 200 mg every four hours or methimazole,20 mg orally every four to six hours | Block new hormone synthesis |
Iodine | (Lugol's) solution, 10 drops (6.25 mg iodide/iodine per drop [0.05 mL]) three times daily | Block the release of thyroid hormone |
Glucocorticoids | Hydrocortisone, 100 mg intravenously every eight hours | Reduce T4-to-T3 conversion, promote vasomotor stability, possibly reduce the autoimmune process in Graves' disease, and possibly treat an associated relative adrenal insufficiency |
An iodinated radiocontrast agent | 0.5 to 1 g once daily. | inhibit the peripheral conversion of T4 to T3 |
Bile acid sequestrants | Cholestyramine,4 g orally four times daily | Decrease enterohepatic recycling of thyroid hormones |
Do's
- Start immediate treatment with a beta blocker
- Acetaminophen should be used instead of aspirin
- Iodine administration should be postponed for at least one hour after administration of thionamide
- Propranolol, PTU, and methimazole can be administered through a nasogastric tube
Don'ts
- The content in this section is in bullet points.
References
- ↑ Roth RN, McAuliffe MJ (1989). "Hyperthyroidism and thyroid storm". Emerg Med Clin North Am. 7 (4): 873–83. PMID 2680469.
- ↑ Kravets I (2016). "Hyperthyroidism: Diagnosis and Treatment". Am Fam Physician. 93 (5): 363–70. PMID 26926973.
- ↑ Vanderpump MP (2011). "The epidemiology of thyroid disease". Br Med Bull. 99: 39–51. doi:10.1093/bmb/ldr030. PMID 21893493.
- ↑ Pearce EN, Farwell AP, Braverman LE (2003). "Thyroiditis". N Engl J Med. 348 (26): 2646–55. doi:10.1056/NEJMra021194. PMID 12826640.
- ↑ "Correction to: Thyroid 2016;26:1343-1421. DOI: 10.1089/thy.2016.0229". Thyroid. 27 (11): 1462. 2017. doi:10.1089/thy.2016.0229.correx. PMC 5672663. PMID 29035639.
- ↑ Karger S, Führer D (2008). "[Thyroid storm--thyrotoxic crisis: an update]". Dtsch Med Wochenschr. 133 (10): 479–84. doi:10.1055/s-2008-1046737. PMID 18302101.